Q4 2024 Management View CEO Thomas Schinecker emphasized that 2024 was an "excellent year," with overall group sales growing ...
Key market drivers of the Insulin Pen and Pump market include the rising prevalence of diabetes, advancements in insulin delivery technologies ...
We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...
2-Year U.S. Treasury Note Continuous Contract $102.871 0.027 0.03% 5-Year U.S. Treasury Note Continuous Contract $106.578 0.141 0.13% 10-Year U.S. Treasury Note Continuous Contract $109.188 0.234 ...